Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

23.70
Delayed Data
As of Sep 30
 +0.11 / +0.47%
Today’s Change
20.97
Today|||52-Week Range
45.00
-44.57%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close23.59
Today’s open23.59
Day’s range23.30 - 24.22
Volume944,399
Average volume (3 months)894,485
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)+9.81%
Earnings growth (next 5 years)+19.19%
Revenue growth (last year)+44.36%
P/E ratio49.4
Price/Sales3.58
Price/Book1.62

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...+1.06+3.01%
SAGESAGE Therapeutics In...+0.52+1.14%
ALDRAlder Biopharmaceuti...+1.48+4.73%
OPHTOphthotech Corp-7.99-14.76%
Data as of 4:14pm ET, 09/30/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.39
Annual revenue (last year)$860.5M
Annual profit (last year)$39.0M
Net profit margin4.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts

Search for Jobs